Insider Shareholders with Direct Ownership of Contineum Therapeutics, Inc. (CTNM)
This section provides a comprehensive overview of the insiders with direct ownership of Contineum Therapeutics, Inc. (CTNM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Contineum Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Daniel S. Lorrain
Chief Scientific Officer |
0 | 7,200 | 168,562 | 2 |
Nov 25, 2024
Reduced 0.6%
|
|
Stephen L. Huhn
CMO & Sr VP, Clinical Dev. |
12,800 | 0 | 12,800 | 1 |
Aug 13, 2024
Added 50.0%
|